Adherence to recommendations for clinical follow-up after benign breast biopsy

M. A. Andrykowski, J. S. Carpenter, J. L. Studts, M. J. Cordova, L. L.C. Cunningham, W. Mager, D. Sloan, D. Kenady, P. McGrath

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Purpose. Women who undergo a benign breast biopsy are at elevated risk for the subsequent development of breast cancer (BC). Therefore, appropriate clinical follow-up of a benign breast biopsy is important. The present study examines the extent and correlates of nonadherence with follow-up recommendations after a benign breast biopsy. Methods. Women (n = 114) who had undergone a benign breast biopsy completed an initial telephone interview within 50 days of their biopsy (mean = 21 days). Additional telephone interviews were completed at 4 and 8 months post-biopsy. Measures of BC risk perception, general and BC-specific distress, BC-related attitudes and beliefs, social support, optimism, and informational coping style were completed. Specific recommendations for clinical follow-up and evidence of actual follow-up were obtained from medical records. Results. Of 103 women given a specific recommendation for clinical follow-up, 34% were classified as nonadherent with follow-up recommendations. Logistic regression analyses indicated that nonadherent women were characterized by younger age, recommendations for follow-up by clinical breast examination alone, greater confidence in their ability to perform breast self-examination properly, higher perceived personal risk for BC, and greater BC-specific distress. Conclusion. Despite the importance of appropriate clinical follow-up of a benign breast biopsy, about one-third of women did not adhere to recommended follow-up. Risk factors for nonadherence suggest potential avenues for interventions to enhance participation in appropriate clinical follow-up.

Original languageEnglish (US)
Pages (from-to)165-178
Number of pages14
JournalBreast Cancer Research and Treatment
Volume69
Issue number2
DOIs
StatePublished - Dec 3 2001

    Fingerprint

Keywords

  • Adherence
  • Biopsy
  • Breast cancer
  • Clinical follow-up
  • Compliance
  • Psychosocial

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Andrykowski, M. A., Carpenter, J. S., Studts, J. L., Cordova, M. J., Cunningham, L. L. C., Mager, W., Sloan, D., Kenady, D., & McGrath, P. (2001). Adherence to recommendations for clinical follow-up after benign breast biopsy. Breast Cancer Research and Treatment, 69(2), 165-178. https://doi.org/10.1023/A:1012272031953